Bayesian Capital Management’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,542
Closed -$171K 1087
2023
Q2
$171K Buy
+10,542
New +$175K 0.02% 654
2017
Q1
Sell
-21,805
Closed -$287K 743
2016
Q4
$287K Buy
+21,805
New +$279K 0.07% 436
2016
Q1
Sell
-11,700
Closed -$189K 459
2015
Q4
$189K Buy
+11,700
New +$171K 0.27% 187

Other funds holding NXGN

Bayesian Capital Management's NXGN Position: Q3 2023 in Review

Bayesian Capital Management sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q3 2023, closing a stake of 10,542 shares — an estimated $171K sold.

Bayesian Capital Management first reported a position in NXGN in Q4 2015 and held it in 3 quarters. The position peaked at $287K in Q4 2016. 214 funds tracked by Wall St. Rank hold NXGN as of Q3 2023.

  • Bayesian Capital Management reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 10,542 NextGen Healthcare, Inc. Common Stock shares in Q3 2023, an estimated $171K.
  • Bayesian Capital Management first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2015 and held it in 3 quarters.
  • Bayesian Capital Management's NextGen Healthcare, Inc. Common Stock position peaked at $287K in Q4 2016.
  • 214 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2023.

Based on Bayesian Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.